Corporate ActionApr 27, 2026, 05:02 PM
INM Amends Preferred Investment Options; Exercise Price Reduced to $0.80
AI Summary
InMed Pharmaceuticals Inc. has amended its preferred investment options with Sabby Volatility Warrant Master Fund, Ltd. and affiliates of H.C. Wainwright & Co., LLC. The exercise price for both sets of options was significantly reduced to $0.80 per common share. Previously, Sabby's options had an exercise price of $2.436, and Wainwright Parties' options ranged from $3.2013 to $82.50.
Key Highlights
- InMed Pharmaceuticals amended preferred investment options with Sabby Volatility Warrant Master Fund, Ltd.
- Sabby Preferred Investment Options exercise price reduced from $2.436 to $0.80 per common share.
- Sabby options cover up to 2,151,478 common shares.
- Wainwright Preferred Investment Options exercise prices reduced to $0.80 per common share.
- Wainwright options previously ranged from $3.2013 to $82.50 per common share.
- Wainwright options cover up to 153,236 common shares.
- Options were offered in private placements under Section 4(a)(2) of the Securities Act.
Price Impact
More from INM